OAKLAND, Calif.--Sugen, a small molecule drug-discovery company wholly owned by Pharmacia and Upjohn, has licensed Pangea Systems' proprietary Clustering and Alignment Tools. Greg Plowman, Sugen's vice-president of molecular biology, said that the performance of Pangea's clustering tool on multiprocessor machines would allow Sugen to reduce the redundancies in its large sequence databases.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.